1 Market Overview
1.1 Product Overview and Scope of β-Nicotinamide Mononucleotide (NMN)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Content Greater than or Equal to 98%
1.3.3 Content Less than 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global β-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.5.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029)
1.5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kingdomway Recent Developments/Updates
3 Competitive Environment: β-Nicotinamide Mononucleotide (NMN) by Manufacturer
3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023)
3.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of β-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.4.2 Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.5 β-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
3.5.1 β-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
3.5.2 β-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
3.5.3 β-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
4.1.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2029)
4.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.3 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.4 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.5 South America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.6 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
5.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2029)
5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2029)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029)
7 North America
7.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
7.2 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
7.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
7.3.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
8.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
8.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
8.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
10.2 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
10.3 South America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
10.3.2 South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 β-Nicotinamide Mononucleotide (NMN) Market Drivers
12.2 β-Nicotinamide Mononucleotide (NMN) Market Restraints
12.3 β-Nicotinamide Mononucleotide (NMN) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of β-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
13.2 Manufacturing Costs Percentage of β-Nicotinamide Mononucleotide (NMN)
13.3 β-Nicotinamide Mononucleotide (NMN) Production Process
13.4 β-Nicotinamide Mononucleotide (NMN) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 β-Nicotinamide Mononucleotide (NMN) Typical Distributors
14.3 β-Nicotinamide Mononucleotide (NMN) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GeneHarbor Recent Developments/Updates
Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 9. Herbalmax Major Business
Table 10. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 11. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Herbalmax Recent Developments/Updates
Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 14. Genex Formulas Major Business
Table 15. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 16. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genex Formulas Recent Developments/Updates
Table 18. Shinkowa Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Shinkowa Pharmaceutical Major Business
Table 20. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 21. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Shinkowa Pharmaceutical Recent Developments/Updates
Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 24. Maac10 Formulas Major Business
Table 25. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Maac10 Formulas Recent Developments/Updates
Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
Table 29. EffePharm Major Business
Table 30. EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 31. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. EffePharm Recent Developments/Updates
Table 33. Bontac Basic Information, Manufacturing Base and Competitors
Table 34. Bontac Major Business
Table 35. Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 36. Bontac β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bontac Recent Developments/Updates
Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
Table 39. CELFULL Major Business
Table 40. CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 41. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. CELFULL Recent Developments/Updates
Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 44. Kingdomway Major Business
Table 45. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 46. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Kingdomway Recent Developments/Updates
Table 48. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 51. Market Position of Manufacturers in β-Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 53. β-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
Table 54. β-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
Table 55. β-Nicotinamide Mononucleotide (NMN) New Market Entrants and Barriers to Market Entry
Table 56. β-Nicotinamide Mononucleotide (NMN) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 58. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 59. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2023) & (US$/Kg)
Table 62. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2024-2029) & (US$/Kg)
Table 63. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 64. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 65. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2023) & (US$/Kg)
Table 68. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2024-2029) & (US$/Kg)
Table 69. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 70. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 71. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2023) & (US$/Kg)
Table 74. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2024-2029) & (US$/Kg)
Table 75. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 76. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 77. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 78. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 79. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 80. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 81. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 84. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 85. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 86. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 87. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 88. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 89. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 92. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 93. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 94. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 95. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 96. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 97. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 100. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 101. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 102. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 103. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2023) & (Kg)
Table 104. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2024-2029) & (Kg)
Table 105. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2023) & (Kg)
Table 108. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2024-2029) & (Kg)
Table 109. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2023) & (Kg)
Table 110. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2024-2029) & (Kg)
Table 111. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2023) & (Kg)
Table 112. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2024-2029) & (Kg)
Table 113. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2024-2029) & (USD Million)
Table 115. β-Nicotinamide Mononucleotide (NMN) Raw Material
Table 116. Key Manufacturers of β-Nicotinamide Mononucleotide (NMN) Raw Materials
Table 117. β-Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 118. β-Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. β-Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type in 2022
Figure 4. Content Greater than or Equal to 98% Examples
Figure 5. Content Less than 98% Examples
Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application in 2022
Figure 8. Health Care Products Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029) & (Kg)
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Average Price (2018-2029) & (US$/Kg)
Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of β-Nicotinamide Mononucleotide (NMN) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029) & (US$/Kg)
Figure 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029) & (US$/Kg)
Figure 33. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 53. China β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. β-Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 74. β-Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 75. β-Nicotinamide Mononucleotide (NMN) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN) in 2022
Figure 78. Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
Figure 79. β-Nicotinamide Mononucleotide (NMN) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source

※参考情報 β-ニコチンアミドモノヌクレオチド（NMN）は、近年注目を集めている生理活性物質の一種であり、特に老化と健康に関連する分野で多くの研究が行われています。NMNは、ニコチンアミド（ナイアシンとも呼ばれる）とリボースが結合したヌクレオチドの一つで、体内において重要な役割を果たしています。ここでは、NMNの定義、特徴、種類、用途、関連技術などについて詳しく説明いたします。 NMNの定義としては、β-ニコチンアミドモノヌクレオチドは、ビタミンB3の一形態であるニコチンアミドから誘導される核酸の一種です。細胞内でのエネルギー生産やDNA修復において重要な役割を果たすことから、特に代謝や細胞の機能に関する研究が多く行われています。 NMNの特徴は、その構造と機能にあります。NMNは、細胞のエネルギー供給に関わる重要な分子であり、NAD+（ニコチンアミドアデニンジヌクレオチド）の前駆体として機能します。NAD+は、細胞内でエネルギーを生成する過程や、遺伝子の修復、老化関連の過程にかかわる酵素の活性化に必要不可欠な物質です。NMNは、体内で簡単にNAD+に変換されるため、NMNの摂取はNAD+のレベルを向上させる手段として利用されています。 NMNにはいくつかの種類がありますが、主に食品やサプリメントとして利用される形が中心です。自然界においては、NMNは果物や野菜、特にブロッコリー、アボカド、トマト、キュウリなどに含まれていますが、これらの食品から必要な量を摂取するのは難しいため、サプリメントとしての利用が増加しています。また、NMNは、粉末、カプセル、液体などさまざまな形態で市販されていますので、自身のライフスタイルや好みによって選ぶことができます。 NMNの用途については、特に老化防止や健康促進に関連するサプリメントとしての利用が多いです。最近の研究では、NMNの摂取がエネルギー代謝を改善し、筋肉機能の維持、認知機能の向上、さらには寿命の延長に寄与する可能性が示唆されています。また、NMNは、糖尿病や肥満、心血管疾患などの生活習慣病に対する予防効果も期待されています。これらの効果は、多くの場合、NAD+のレベルが上昇することによって生じると考えられています。 関連技術としては、NMNの生産方法やそれを利用した医薬品の開発が挙げられます。NMNは、化学合成や生物合成といった方法で製造することが可能ですが、近年の研究では微生物を用いたバイオプロセスによる製造方法が注目されています。この方法は、より持続可能で効率的なNMN生産が可能になると期待されています。また、NMNがNAD+の前駆体であることから、NAD+を直接補充する医薬品の開発も進められています。 さらに、NMNの研究は日々進展しており、この分野では多くの新しい知見が報告されています。特に、老化に伴うNAD+の減少が、様々な疾患や生理的変化に影響を与えることが明らかになってきています。そのため、NMNやその他のNAD+関連の分子が、未来の医療や予防医学において重要な役割を果たす可能性があります。 NMNの摂取について注意点もあります。サプリメントとしてのNMNは比較的安全とされているものの、個人差や摂取量に応じて副作用が現れる可能性もゼロではありません。特に、基礎疾患をお持ちの方や妊娠中・授乳中の方は、摂取前に医師に相談することをお勧めいたします。また、NMNの効果は個人差があるため、使用する際には自分自身の体調やニーズに合った形で取り入れることが重要です。 結論として、β-ニコチンアミドモノヌクレオチド（NMN）は、老化や健康維持に関連する重要な化合物であり、今後の研究によってさらなる効果や利用法が明らかになってくることが期待されます。老化防止や健康促進を目的としたサプリメントとしての需要は高まり続けており、科学的な根拠をもとに適切に使用することで、より良いライフスタイルの実現に寄与することができるでしょう。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/